Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway

Fig. 4

miR-145 sensitized ESCC to DDP through inhibiting AKT3. a Cell viability was detected by MTT assay in EC109 and KYSE-30 cells exposed to DDP after transfection with miR-145 mimics, sh-AKT3, or miR-145 mimcis + pcDNA3.1-AKT3. b Analysis and quantifications of DDP IC50 value. All the results were shown as mean ± SD (n = 3), which were three separate experiments performed in triplicate. *p < 0.05 and **p < 0.01

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us